Kilitch Drugs

{
  "main_header": {
    "sid": 189669,
    "name": "Kilitch Drugs",
    "stock_name": "Kilitch Drugs",
    "full_name": "Kilitch Drugs (India) Ltd",
    "name_url": "stocks-analysis/kilitch-drugs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "338.10",
    "chg": -1.1,
    "chgp": "-0.32%",
    "dir": -1,
    "prev_price": "339.20",
    "mcapval": "588.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524500,
    "symbol": "KILITCH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE729D01010",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "9.35 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-faces-bearish-momentum-amid-technical-downturn-3782472",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KilitchDrugsInd_technicaldot_3782472.png",
        "date": "2026-01-06 08:04:14",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite recent short-term gains, the stock’s technical parameters have deteriorated, prompting a downgrade in its Mojo Grade to Sell as of 1 September 2025. This article analyses the evolving price momentum, technical indicator signals, and broader market context to provide a comprehensive view of the stock’s outlook."
      },
      {
        "title": "Kilitch Drugs (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-sell-3778866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KilitchDrugsInd_mojoScore_3778866.png",
        "date": "2026-01-02 10:10:03",
        "description": "Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Kilitch Drugs (India) Ltd: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-3775599",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KilitchDrugsInd_technicaldot_3775599.png",
        "date": "2025-12-31 08:01:34",
        "description": "Kilitch Drugs (India) Ltd has experienced a nuanced shift in its technical momentum as it navigates a complex market environment. Recent data reveals a transition from a bearish to a mildly bearish trend, with key indicators such as MACD, RSI, and moving averages signalling a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Kilitch Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kilitch-drugs-fallingrising-3766041",
        "imagepath": "",
        "date": "2025-12-23 01:35:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>The stock’s gain of ₹17.5 on the day represents a significant outperformance compared to the sector, with Kilitch Drugs exceeding sector returns by 4.59%. Intraday, the share price reached a high of ₹372.3, marking an impressive 11.57% increase from its previous close, although it settled lower by the end of trading. The wide intraday range of ₹36.4 indicates heightened volatility and active trading interest during the session.</p>\n<p>Despite this strong daily performance, the weighted average price suggests that a larger volume of shares traded closer to the lower end of the day’s price range. This could imply some selling pressure or cautious profit-taking as the stock approached its intraday peak.</p>\n<p><strong>Technical Indica..."
      },
      {
        "title": "Kilitch Drugs Sees Revision in Market Evaluation Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-downgraded-to-sell-by-marketsmojo-amid-weak-financial-and-technical-signals-3765649",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KilitchDrugs_mojoScore_3765649.png",
        "date": "2025-12-22 10:10:04",
        "description": "Kilitch Drugs, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a more cautious analytical perspective. This shift follows a detailed review of the company’s financial and technical parameters, highlighting challenges in profitability and market momentum despite some stable valuation aspects."
      },
      {
        "title": "Kilitch Drugs (India) Sees Shift in Technical Momentum Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-faces-bearish-momentum-amid-technical-downturn-3752641",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KilitchDrugsInd_technicaldot_3752641.png",
        "date": "2025-12-09 08:02:55",
        "description": "Kilitch Drugs (India), a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent data reveals a transition in key technical indicators, signalling a more cautious outlook as the stock navigates a challenging environment."
      },
      {
        "title": "Is Kilitch Drugs technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kilitch-drugs-technically-bullish-or-bearish-3747608",
        "imagepath": "",
        "date": "2025-12-05 08:23:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Kilitch Drugs’ Current Market Position</strong></p>\n<p>Kilitch Drugs is trading at ₹343.25, marginally above its previous close of ₹341.80. The stock’s 52-week range spans from ₹271.30 to ₹500.05, indicating significant volatility over the past year. Today’s intraday movement saw a high of ₹360.00 and a low of ₹337.95, reflecting some short-term price fluctuations.</p>\n<p>While the stock price remains comfortably above its yearly low, it is still well below the 52-week high, suggesting that the stock has not regained its peak momentum. This price behaviour is an important backdrop when analysing the technical indicators.</p>\n<p><strong>Technical Trend and Moving Averages</strong></p>\n<p>The overall technical trend for Kilitch Drugs recently shifted from bearish to mildly bearish ..."
      },
      {
        "title": "Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-technical-momentum-shifts-amid-mixed-market-signals-3747477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KilitchDrugsInd_technicaldot_3747477.png",
        "date": "2025-12-05 08:01:12",
        "description": "Kilitch Drugs (India) has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish indicators across multiple timeframes. Recent market data reveals a subtle transition in price dynamics, with key technical parameters signalling a cautious outlook for the pharmaceutical company amid broader sector trends."
      },
      {
        "title": "Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-shares-shift-to-bearish-momentum-amid-technical-downgrade-3745177",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KilitchDrugsInd_technicaldot_3745177.png",
        "date": "2025-12-04 08:01:15",
        "description": "Kilitch Drugs (India) has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across key indicators. As the stock navigates a challenging phase within the Pharmaceuticals & Biotechnology sector, recent evaluation adjustments highlight evolving market dynamics and investor sentiment."
      }
    ],
    "total": 271,
    "sid": "189669",
    "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669"
  },
  "announcements": [
    {
      "details": "Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated December 09, 2019, titled \"Kilitch Drugs to set-up second green field Project in Ethiopia at an investment of USD 5 mn\".",
      "source": "NSE",
      "caption": "Kilitch Drugs (India) Limited - Press Release",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Kilitch Drugs (India) Limited has informed the Exchange regarding Board meeting held on November 13, 2019.",
      "source": "NSE",
      "caption": "Kilitch Drugs (India) Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    },
    {
      "details": " <table><tr><td>Kilitch Drugs (India) Limited has informed the Exchange regarding Board meeting held on September 19, 2019. </td></tr></table>",
      "source": "NSE",
      "caption": "Outcome of Board Meeting",
      "datetime": "19-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19",
          "dt": "2019-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn

2026-01-06 08:04:14

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite recent short-term gains, the stock’s technical parameters have deteriorated, prompting a downgrade in its Mojo Grade to Sell as of 1 September 2025. This article analyses the evolving price momentum, technical indicator signals, and broader market context to provide a comprehensive view of the stock’s outlook.

Read full news article

Kilitch Drugs (India) Ltd is Rated Sell

2026-01-02 10:10:03

Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Kilitch Drugs (India) Ltd: Technical Momentum Shifts Amid Mixed Market Signals

2025-12-31 08:01:34

Kilitch Drugs (India) Ltd has experienced a nuanced shift in its technical momentum as it navigates a complex market environment. Recent data reveals a transition from a bearish to a mildly bearish trend, with key indicators such as MACD, RSI, and moving averages signalling a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Why is Kilitch Drugs falling/rising?

2025-12-23 01:35:22

Short-Term Price Movement and Market Context

The stock’s gain of ₹17.5 on the day represents a significant outperformance compared to the sector, with Kilitch Drugs exceeding sector returns by 4.59%. Intraday, the share price reached a high of ₹372.3, marking an impressive 11.57% increase from its previous close, although it settled lower by the end of trading. The wide intraday range of ₹36.4 indicates heightened volatility and active trading interest during the session.

Despite this strong daily performance, the weighted average price suggests that a larger volume of shares traded closer to the lower end of the day’s price range. This could imply some selling pressure or cautious profit-taking as the stock approached its intraday peak.

Technical Indica...

Read full news article

Kilitch Drugs Sees Revision in Market Evaluation Amidst Mixed Financial Signals

2025-12-22 10:10:04

Kilitch Drugs, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a more cautious analytical perspective. This shift follows a detailed review of the company’s financial and technical parameters, highlighting challenges in profitability and market momentum despite some stable valuation aspects.

Read full news article

Kilitch Drugs (India) Sees Shift in Technical Momentum Amid Market Volatility

2025-12-09 08:02:55

Kilitch Drugs (India), a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent data reveals a transition in key technical indicators, signalling a more cautious outlook as the stock navigates a challenging environment.

Read full news article

Is Kilitch Drugs technically bullish or bearish?

2025-12-05 08:23:26

Overview of Kilitch Drugs’ Current Market Position

Kilitch Drugs is trading at ₹343.25, marginally above its previous close of ₹341.80. The stock’s 52-week range spans from ₹271.30 to ₹500.05, indicating significant volatility over the past year. Today’s intraday movement saw a high of ₹360.00 and a low of ₹337.95, reflecting some short-term price fluctuations.

While the stock price remains comfortably above its yearly low, it is still well below the 52-week high, suggesting that the stock has not regained its peak momentum. This price behaviour is an important backdrop when analysing the technical indicators.

Technical Trend and Moving Averages

The overall technical trend for Kilitch Drugs recently shifted from bearish to mildly bearish ...

Read full news article

Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals

2025-12-05 08:01:12

Kilitch Drugs (India) has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish indicators across multiple timeframes. Recent market data reveals a subtle transition in price dynamics, with key technical parameters signalling a cautious outlook for the pharmaceutical company amid broader sector trends.

Read full news article

Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals

2025-12-04 08:01:15

Kilitch Drugs (India) has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across key indicators. As the stock navigates a challenging phase within the Pharmaceuticals & Biotechnology sector, recent evaluation adjustments highlight evolving market dynamics and investor sentiment.

Read full news article

View All News